Dear Reader,
Welcome to today's daily dividend and earnings report, where we help you get ready to stay ahead of the game with valuable insights and ratings from top Wall Street analysts.
Please note that while we provide you with valuable information, we are not recommending these companies.
So, let's dive right in...
Below is our latest Dividend Report:
Quest Diagnostics Incorporated
Symbol: DGX
Recent DGX Stock Price: $132.39
Average Analyst Price Target: $143.00 (8.01%)
DGX Market Cap: $14.66B
Expected Ex-Dividend Date for DGX stock: Apr 05 2024
Expected Payment Date for DGX stock: Apr 22 2024
Expected Dividend & Yield for DGX stock: 2.27%
Recent Analyst Action: David S, analyst at Truist Financial, reiterates coverage on Quest Diagnostics Incorporated (DGX) stock in the Healthcare sector with a Hold rating and a price target of $145 (2 weeks ago).
TipRanks.com also reports that Quest Diagnostics Incorporated stock currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $143.00 . The target pricing ranges from a high forecast of $155 down to a low forecast of $135. Quest Diagnostics Incorporated (DGX)’s last closing stock price was $132.39 which would put the average price target at 8.01% upside.Here are 3rd party ratings for DGX stock:
- TipRanks.com: Hold
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Weak buy
- Zacks.com: Sell, Top 34% (86 out of 252)
--------------------------------------------------------------------------
McCormick & Company, Incorporated
Symbol: MKC
Recent MKC Stock Price: $76.25
Average Analyst Price Target: $77.60 (1.77%)
MKC Market Cap: $20.44B
Expected Ex-Dividend Date for MKC stock: Apr 05 2024
Expected Payment Date for MKC stock: Apr 22 2024
Expected Dividend & Yield for MKC stock: 2.20%
Recent Analyst Action: John Staszak, analyst at Argus Research, reiterates coverage on McCormick & Company, Incorporated (MKC) stock in the Consumer Defensive sector with a Buy rating and a price target of $88 (1 day ago).
TipRanks.com also reports that McCormick & Company, Incorporated stock currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $77.60 . The target pricing ranges from a high forecast of $88 down to a low forecast of $74. McCormick & Company, Incorporated (MKC)’s last closing stock price was $76.25 which would put the average price target at 1.77% upside.Here are 3rd party ratings for MKC stock:
- TipRanks.com: Hold
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Top 28% (70 out of 252)
--------------------------------------------------------------------------
OGE Energy Corp.
Symbol: OGE
Recent OGE Stock Price: $34.33
Average Analyst Price Target: $34.60 (0.79%)
OGE Market Cap: $6.88B
Expected Ex-Dividend Date for OGE stock: Apr 05 2024
Expected Payment Date for OGE stock: Apr 26 2024
Expected Dividend & Yield for OGE stock: 4.86%
Recent Analyst Action: Nicholas Campanella, analyst at Barclays, reiterates coverage on OGE Energy Corp. (OGE) stock in the Utilities sector with a Buy rating and a price target of $34 (2 weeks ago).
TipRanks.com also reports that OGE Energy Corp. stock currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $34.60 . The target pricing ranges from a high forecast of $37 down to a low forecast of $32. OGE Energy Corp. (OGE)’s last closing stock price was $34.33 which would put the average price target at 0.79% upside.Here are 3rd party ratings for OGE stock:
- TipRanks.com: Hold
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Weak sell
- Zacks.com: Hold, Top 37% (93 out of 252)
--------------------------------------------------------------------------
Invesco Mortgage Capital Inc.
Symbol: IVR
Recent IVR Stock Price: $9.48
Average Analyst Price Target: $8.25 (-12.97%)
IVR Market Cap: $459.41M
Expected Ex-Dividend Date for IVR stock: Apr 05 2024
Expected Payment Date for IVR stock: Apr 26 2024
Expected Dividend & Yield for IVR stock: 16.88%
Recent Analyst Action: Derek Hewett, analyst at Bank of America Securities, reiterates coverage on Invesco Mortgage Capital Inc. (IVR) stock in the Real Estate sector with a Sell rating and a price target of $8.5 (2 months ago).
TipRanks.com also reports that Invesco Mortgage Capital Inc. stock currently has 2 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $8.25 . The target pricing ranges from a high forecast of $8.5 down to a low forecast of $8. Invesco Mortgage Capital Inc. (IVR)’s last closing stock price was $9.48 which would put the average price target at -12.97% upside.Here are 3rd party ratings for IVR stock:
- TipRanks.com: Hold
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Bottom 30% (176 out of 252)
--------------------------------------------------------------------------
And there you have it...
Keep in mind, if you purchase a security on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell before the ex-dividend date, you also are selling away your right to the dividend.
If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information.
Here's today's Earnings Report...
We has just identified several companies that are expected to release earnings this week (even starting tomorrow). Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
The Greenbrier Companies, Inc.
Symbol: GBX
Recent Price: $54.48
Average Analyst Price Target: $45.75 (-16.02%)
Market Cap: $1.69B
Last Year's EPS: $0.92
Consensus EPS Forecast: $0.73
Expected Earnings Date: Apr 05 2024
Recent Analyst Action: Matt Elkott, analyst at TD Cowen, reiterates coverage on The Greenbrier Companies, Inc. (GBX) in the Industrials sector with a Buy rating and a price target of $53 (3 weeks ago).
TipRanks.com also reports that The Greenbrier Companies, Inc. currently has 4 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $45.75 . The target pricing ranges from a high forecast of $53 down to a low forecast of $40. The Greenbrier Companies, Inc. (GBX)’s last closing price was $54.48 which would put the average price target at -16.02% upside.
Here are 3rd party ratings for GBX:
- TipRanks.com: Hold
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Hold, Top 38% (96 out of 252)
Click for chart >>
--------------------------------------------------------------------------
Byrna Technologies Inc.
Symbol: BYRN
Recent Price: $13.13
Average Analyst Price Target: $12.75 (-2.89%)
Market Cap: $298.53M
Last Year's EPS: -$0.13
Consensus EPS Forecast: -$0.04
Expected Earnings Date: Apr 05 2024
Recent Analyst Action: James McIlree, analyst at Dawson James, reiterates coverage on Byrna Technologies Inc. (BYRN) in the Industrials sector with a Hold rating and a price target of n/a (3 weeks ago).
TipRanks.com also reports that Byrna Technologies Inc. currently has 2 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $12.75 . The target pricing ranges from a high forecast of $14 down to a low forecast of $11.5. Byrna Technologies Inc. (BYRN)’s last closing price was $13.13 which would put the average price target at -2.89% upside.
Here are 3rd party ratings for BYRN:
- TipRanks.com: Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Strong Buy, Top 31% (77 out of 252)
Click for chart >>
--------------------------------------------------------------------------
Cue Biopharma, Inc.
Symbol: CUE
Recent Price: $1.77
Average Analyst Price Target: $9.40 (431.07%)
Market Cap: $86.10M
Last Year's EPS: -$0.24
Consensus EPS Forecast: -$0.29
Expected Earnings Date: Apr 08 2024
Recent Analyst Action: Edward Tenthoff, analyst at Piper Sandler, reiterates coverage on Cue Biopharma, Inc. (CUE) in the Healthcare sector with a Buy rating and a price target of $8 (22 hours ago).
TipRanks.com also reports that Cue Biopharma, Inc. currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $9.40 . The target pricing ranges from a high forecast of $8 down to a low forecast of $10. Cue Biopharma, Inc. (CUE)’s last closing price was $1.77 which would put the average price target at 431.07% upside.
Here are 3rd party ratings for CUE:
- TipRanks.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 29% (74 out of 252)
Click for chart >>
--------------------------------------------------------------------------
Neogen Corporation
Symbol: NEOG
Recent Price: $14.26
Average Analyst Price Target: $23.50 (64.80%)
Market Cap: $3.09B
Last Year's EPS: $0.11
Consensus EPS Forecast: $0.15
Expected Earnings Date: Apr 09 2024
Recent Analyst Action: David Westenberg, analyst at Piper Sandler, reiterates coverage on Neogen Corporation (NEOG) in the Healthcare sector with a Hold rating and a price target of $19 (2 months ago).
TipRanks.com also reports that Neogen Corporation currently has 2 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $23.50 . The target pricing ranges from a high forecast of $28 down to a low forecast of $19. Neogen Corporation (NEOG)’s last closing price was $14.26 which would put the average price target at 64.80% upside.
Here are 3rd party ratings for NEOG:
- TipRanks.com: Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Sell, Top 38% (95 out of 252)
Click for chart >>
--------------------------------------------------------------------------
Just a reminder, securities are very volatile, so please do your own research. Also, while we list the ratings of various 3rd party services, we are not making any recomendations.
To your financial future!
The Editor
DividendPress.com helps you find the best performing dividend stocks. We alert our subscribers of coming ex-dividend dates.